Smart people say the darnedest things…
TJX reported earnings this morning and the stock appears to be diving.
JBLU was covered a couple weeks ago.
The biotech fallout is squarely on MYL’s hands and the stock price has paid… the price. Now could MYL be a buy? Here’s what I see from the technical side.
Game on Garth…
Biotech and pharma stocks are feeling the brunt of MYL’s effort to make a little money on their epipens before patent expiration.
Ask any parent, it’s more important to get the kids to school on time than it is to be at work
It’s back to school week for me…and thousands of other drivers too
That’s the sound after those EIA oil inventory numbers came out yesterday,
That’s the answer to the question, “Just how much demand is there for gasoline?”
It’s come to this.
We’ve come so far and accomplished so little.
Don’t do it…don’t do it…
Like trading, it doesn’t have to make sense, it only has to make money.